REQUEST A DEMO
Total
USD $0.00
Search more companies

Silco Pharmaceuticals Limited (Bangladesh)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Silco Pharmaceuticals Limited Profile Updated: July 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyratics, Anti-inflammatory Drugs, Antiulcerants, Multi medicines which are sold mainly in local market.The Company production and selling of veterinary medicine also.
Mission:
We are committed to developing safe and effective pharmaceuticals products for the people.
Vision:
To discover, develop and deliver innovative Medicines that help patients prevail over serious diseases.
History .
1995 : The Company was incorporated in Bangladesh as Public Limited Company on January 25, 1995, as Company limited by Shares under the Companies Act 1994 vide registration no. C27781(1627)/95.
2003 : The Company started it s commercial operation on 30 October 2003.
2019 : The Company was listed on Dhaka Stock Exchange and Chittagong Stock Exchange on 13 June 2019.
.

Legal Address
41, Nurani, Bankalapara, Subid Bazar
Sylhet; Bangladesh; Postal Code: 3100

Contact Details: Purchase the Silco Pharmaceuticals Limited report to view the information.

Website: http://www.silcopharma.com

Basic Information
Total Employees:
Purchase the Silco Pharmaceuticals Limited report to view the information.
Outstanding Shares:
Purchase the Silco Pharmaceuticals Limited report to view the information.
Financial Auditors:
Purchase the Silco Pharmaceuticals Limited report to view the information.
Incorporation Date:
1995
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
47.34%
Purchase this report to view the information.
38.99%
Purchase this report to view the information.
13.67%
Company Performance
Financial values in the chart are available after Silco Pharmaceuticals Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BDT. Absolute financial data is included in the purchased report.
Net sales revenue
-11.91%
Total operating revenue
-11.91%
Operating profit (EBIT)
-38.56%
Net Profit (Loss) for the Period
-39.43%
Total assets
1.98%
Total equity
1.53%
Operating Profit Margin (ROS)
-7.3%
Net Profit Margin
-5.83%
Return on Equity (ROE)
-1.17%
Quick Ratio
0.18%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?